Ignite Creation Date:
2025-12-24 @ 5:45 PM
Ignite Modification Date:
2026-01-24 @ 7:47 PM
Study NCT ID:
NCT01210768
Status:
UNKNOWN
Last Update Posted:
2021-11-23
First Post:
2010-08-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Pegylated Liposomal Doxorubicin and Cyclophosphamide in Her2-negative Stage I and II Breast Cancer Patients
Sponsor:
TTY Biopharm
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-06
Start Date Type:
None
Primary Completion Date:
2022-10-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-10-31
Completion Date Type:
ESTIMATED
First Submit Date:
2010-08-31
First Submit QC Date:
None
Study First Post Date:
2010-09-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-22
Last Update Post Date:
2021-11-23
Last Update Post Date Type:
ACTUAL